Suppr超能文献

从阳性和阴性症状量表(PANSS)主成分分析中提取的抑郁维度在未服用药物的精神分裂症患者中的效度。

Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia.

作者信息

El Yazaji Meriem, Battas Omar, Agoub Mohamed, Moussaoui Driss, Gutknecht Christel, Dalery Jean, d'Amato Thierry, Saoud Mohamed

机构信息

Centre Psychiatrique Universitaire Ibn Rochd, rue Tarik Ibn Ziad, Casablanca, Morocco.

出版信息

Schizophr Res. 2002 Jul 1;56(1-2):121-7. doi: 10.1016/s0920-9964(01)00247-x.

Abstract

Depressive symptoms frequently occur during the course of schizophrenia. This study explored the relationships between the schizophrenia symptomatology and three measures of depression. Eighty-one drug-free inpatients with acute schizophrenia were assessed with the positive and negative syndrome scale (PANSS), the Calgary depression scale for schizophrenia (CDSS), and the Hamilton rating scale for depression (HAM-D). The depressive subscale of PANSS (PANSS-D) was also considered as a third scale for measuring depression. A principal component analysis (PCA) of PANSS items identified five clinical dimensions of schizophrenia called 'negative', 'positive', 'anxio-depressive', 'excitement', and 'disorganisation and others'. Our anxio-depressive dimension (PANSS-ad) was strictly identical with the PANSS-D. Scores on CDSS and HAM-D were highly inter-correlated and highly correlated with the PANSS-ad. Furthermore, while scores on CDSS were correlated only with this dimension, scores at HAM-D were also positively correlated with the negative dimension and negatively correlated with the excitement dimension. In conclusion, our results suggest that PANSS evaluation itself may be sufficient to give a correct approximation of the depression in patients with schizophrenia. However, depression scales are of course needed to assess specifically depressive symptoms in patients with schizophrenia; hence, the CDSS could be a more specific instrument than HAM-D.

摘要

抑郁症状在精神分裂症病程中经常出现。本研究探讨了精神分裂症症状学与三种抑郁测量方法之间的关系。对81名未服用药物的急性精神分裂症住院患者使用阳性和阴性症状量表(PANSS)、精神分裂症卡尔加里抑郁量表(CDSS)和汉密尔顿抑郁评定量表(HAM-D)进行评估。PANSS的抑郁分量表(PANSS-D)也被视为测量抑郁的第三个量表。对PANSS项目进行主成分分析(PCA)确定了精神分裂症的五个临床维度,即“阴性”、“阳性”、“焦虑抑郁”、“兴奋”以及“紊乱及其他”。我们的焦虑抑郁维度(PANSS-ad)与PANSS-D完全相同。CDSS和HAM-D的得分高度相互关联,且与PANSS-ad高度相关。此外,虽然CDSS得分仅与该维度相关,但HAM-D得分也与阴性维度呈正相关,与兴奋维度呈负相关。总之,我们的结果表明,PANSS评估本身可能足以对精神分裂症患者的抑郁情况做出正确的近似评估。然而,当然需要抑郁量表来专门评估精神分裂症患者的抑郁症状;因此,CDSS可能是比HAM-D更具特异性的工具。

相似文献

2
Scales for evaluating depressive symptoms in Chinese patients with schizophrenia.
J Nerv Ment Dis. 2009 Feb;197(2):140-2. doi: 10.1097/NMD.0b013e31819636a5.
3
Diagnostic validity of assessment scales for depression in patients with schizophrenia.
Psychiatry Res. 2006 Sep 30;144(1):57-63. doi: 10.1016/j.psychres.2005.10.002. Epub 2006 Aug 10.
5
Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS).
J Affect Disord. 2000 May;58(2):107-15. doi: 10.1016/s0165-0327(99)00075-0.
6
The Greek version of the calgary depression scale for schizophrenia.
Psychiatry Res. 2000 May 15;94(2):163-71. doi: 10.1016/s0165-1781(00)00137-2.
7
Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.
Schizophr Res. 2004 Jun 1;68(2-3):349-56. doi: 10.1016/S0920-9964(02)00490-5.
8
The Persian version of the Calgary Depression Scale for Schizophrenia (CDSS-P).
Asian J Psychiatr. 2019 Oct;45:44-49. doi: 10.1016/j.ajp.2019.08.017. Epub 2019 Aug 30.
10
Comparison of four scales measuring depression in schizophrenic inpatients.
Eur Psychiatry. 2000 Jun;15(4):274-7. doi: 10.1016/s0924-9338(00)00232-7.

引用本文的文献

1
Poor insight and self-disorders in schizophrenia: an empirical study.
Eur Arch Psychiatry Clin Neurosci. 2025 Jun 3. doi: 10.1007/s00406-025-02035-7.
2
COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS).
EClinicalMedicine. 2025 Apr 11;82:103155. doi: 10.1016/j.eclinm.2025.103155. eCollection 2025 Apr.
3
COSMIN review of the PANSS Marder factor solution and other factor models in people with schizophrenia.
Schizophrenia (Heidelb). 2025 Mar 31;11(1):51. doi: 10.1038/s41537-025-00600-6.
5
Impact of cognitive performance and negative symptoms on psychosocial functioning in Czech schizophrenia patients.
Schizophrenia (Heidelb). 2023 Jul 17;9(1):43. doi: 10.1038/s41537-023-00374-9.
7
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia.
Cochrane Database Syst Rev. 2022 Nov 24;11(11):CD014384. doi: 10.1002/14651858.CD014384.pub2.
8
A Review of Pharmaceutical Robot based on Hyperspectral Technology.
J Intell Robot Syst. 2022;105(4):75. doi: 10.1007/s10846-022-01602-7. Epub 2022 Jul 22.
9
FACTORS ASSOCIATED WITH DEPRESSION IN PATIENTS WITH SCHIZOPHRENIA.
Acta Clin Croat. 2020 Dec;59(4):605-614. doi: 10.20471/acc.2020.59.04.06.
10
Cross-Validation of Functional MRI and Paranoid-Depressive Scale: Results From Multivariate Analysis.
Front Psychiatry. 2019 Nov 25;10:869. doi: 10.3389/fpsyt.2019.00869. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验